|Bid||7,714.00 x N/A|
|Ask||7,718.00 x N/A|
|Day's Range||7,574.00 - 7,734.00|
|52 Week Range||6,854.00 - 10,010.00|
|Beta (5Y Monthly)||0.35|
|PE Ratio (TTM)||64.96|
|Earnings Date||Aug 06, 2021|
|Forward Dividend & Yield||0.75 (1.00%)|
|Ex-Dividend Date||Apr 29, 2021|
|1y Target Est||N/A|
Forcing euro derivatives clearing to move from London to the European Union would bump up costs for customers and put EU firms at a competitive disadvantage to international peers, the London Stock Exchange Group argued in a note to clients. The EU is studying how trillions of euros in interest rate swaps positions could be shifted from LSEG's LCH clearing arm in London, where the bulk of the global market is cleared, to rival Deutsche Boerse's Eurex in Frankfurt.
Forcing euro derivatives clearing to move from London to the European Union would bump up costs for customers and put EU firms at a competitive disadvantage to their international peers, the London Stock Exchange Group said in a note to clients. "Restricting access to the EU economy and the Euro would place EU firms in competitive disadvantage against their peers and would also increase risk to financial stability both in the EU and more widely," LSEG said in a note issued on Friday.
London-based Babylon Health will join the Nasdaq through a $4.2bn SPAC deal in a snub to the UK.